Likewise, the well-recognized effects of RYGB in obese humans and rodents [4, 66] demonstrate its ability to overcome the acquired leptin resistance of diet- induced obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.